The QualityStocks Daily Monday, October 15th, 2018

Today's Top 3 StockMarketWatch

NetworkNewsWire (HOILF) +52.83%

QualityStocks (FIFG) +58.42%

TopPennyStockMovers (GNBT) +57.14%

The QualityStocks Daily Stock List

CanAlaska Uranium Ltd. (CVVUF)

Dividend Investor, Morningstar, Stockhouse, Streetwise Reports, OTC Markets Group, InvestorsHub, Resource World, and FeedBlitz reported on CanAlaska Uranium Ltd. (CVVUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CanAlaska Uranium Ltd. is an exploration stage enterprise with its corporate headquarters in Vancouver, British Columbia. The Company concentrates on two important projects in the Athabasca Basin in the Province of Saskatchewan. A project generator, CanAlaska Uranium lists on the OTC Markets Group’s OTCQB.

The Company holds interests in approximately 102,870 hectares (254,000 acres), one of the largest land positions in Canada's Athabasca Basin region. Its strategic holdings have attracted major international mining companies. At present, CanAlaska is working with Cameco and Denison at two of CanAlaska’s properties in the Eastern Athabasca Basin.

CanAlaska Uranium’s projects include Cree East, West McArthur, NW Manitoba, and base metals and gold projects and other uranium projects and its diamond projects. The Cree East project is a high-priority property positioned in the southeastern portion of the Athabasca Basin.

The West McArthur project is adjoining the world’s richest uranium mine -Cameco's McArthur River. The goal at West McArthur is a large unconformity uranium deposit. In addition, $20 million of work successfully identified seven target areas.

The Company’s NW Manitoba project lies in northwest Manitoba just east of the border of northeast Saskatchewan. It is 70 kilometers north of Reindeer Lake.

CanAlaska Uranium has new targets developed at the Thompson Nickel Belt Properties. In Manitoba, it has continued Project Generation activities, with licence acquisitions in the Thompson Nickel Belt. Compilation work has continued. More targets have been developed on the Strong and Hunter properties.

Furthermore, the Company acquired four new claims groups in the western Athabasca Basin for diamond exploration. Three of these are in the area just north of current claims in the Patterson Lake area.

Last month, CanAlaska Uranium reported that it entered into Letters of Intent (LOIs) with Canada Metals Ltd. for an Option-Purchase of the Manibridge nickel project, and an Option to earn 70 percent of the Strong nickel project. Canada Metals is presently planning to undertake an IPO (Initial Public Offering) to list on the Australian Securities Exchange (ASX). Both projects will receive significant drill programs following the proposed financing of Canada Metals pursuant to its ASX listing. Canada Metals is an Australian-incorporated public unlisted company headquartered in Melbourne, Australia, and supported by Peak Asset Management investment group.

President Peter Dasler said, "This is a great step forward for CanAlaska, as we get a timely funding of exploration on two of our three nickel projects. Historical exploration work has been compiled on each property and there are a number of compelling nickel targets. We get to participate alongside a good technical group with strong funding sources."

CanAlaska Uranium Ltd. (CVVUF), closed Monday's trading session at $0.2791, up 0.43%, on 4,770 volume with 8 trades. The average volume for the last 3 months is 24,014 and the stock's 52-week low/high is $0.208/$0.37.


NaturalShrimp, Inc. (SHMP)

OTC Dynamics, ThePennyPicks, SmallCapVoice, Born2Invest, Morningstar, Market Screener, Pennystockmania, PennyPickGains, WallstreetSurfers, Investors Hangout, The Street, and TradingView reported on NaturalShrimp, Inc. (SHMP), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, NaturalShrimp, Inc. is a global leader in aquaculture technology. The Company has developed and tested the first commercially-viable system for growing shrimp indoors. The system utilizes a proprietary technology to reliably produce healthy, naturally-grown shrimp weekly without the use of antibiotics or toxic chemicals. NaturalShrimp has developed a technology to produce fresh, gourmet-grade shrimp dependably and economically in an indoor, re-circulating, saltwater facility.

NaturalShrimp’s corporate office is in Dallas, Texas. Its production facility is outside of San Antonio, Texas. NaturalShrimp, Inc. owns 100 percent of NaturalShrimp Corporation, formed to operate in the U.S. and Canada, and 100 percent of NaturalShrimp Global, Inc., established to form International Joint Venture (JV) Partnerships.

NaturalShrimp operates a closed-system saltwater aquaculture facility. The facility produces high-grade Pacific White shrimp. It accomplishes this without using the antibiotics and chemical additives today’s shrimp farms require. The technology causes ammonia (NH3) to break down into risk-free nitrogen and hydrogen gas. Therefore, this eliminates one of the historically most demanding problems in shrimp aquaculture.

NaturalShrimp’s production facilities will be the aquaculture industry’s first truly eco-friendly, sustainable way of cultivating shrimp in high density environments.

The Company’s eco-friendly, bio-secure design does not depend on ocean water. It recreates the natural ocean environment allowing for high-density production that can undergo replication anywhere in the world.

The NaturalShrimp Automated Monitoring and Control system employs individual tank monitors to automatically control the feeding, the oxygenation, and the temperature of each of the facility tanks independently. Furthermore, a facility computer, running custom software, communicates with each of the controllers and performs more data acquisition functions that can report back to a supervisory computer from anywhere worldwide.

NaturalShrimp has installed an enhanced version of its patent pending, vibrio suppression technology system at the La Coste, Texas production facility. Recently, NaturalShrimp announced that its vibrio suppression technology system received extensive coverage from multiple Texas-based newspapers.

The design of the Company's vibrio suppression technology is to create higher sustainable shrimp population densities, consistent production, improved growth, higher survival rates, and top-quality food conversion in an all-natural ocean-type environment. Mr. Gerald Easterling, President, and one of NaturalShrimp's three Co-Founders, predicted, "What you see here will revolutionize indoor aquatic species and not just shrimp."

The original article stated, "That could have implications for a worldwide aquaculture industry estimated at more than $163 billion." The original article was written by Lynn Brezosky for the San Antonio Express-News. It was republished by permission in the Dallas, Ft. Worth and Waco newspapers.

NaturalShrimp, Inc. (SHMP), closed Monday's trading session at $0.0075, down 4.58%, on 1,259,965 volume with 32 trades. The average volume for the last 3 months is 1,120,236 and the stock's 52-week low/high is $0.0065/$1.00.


SolarWindow Technologies, Inc. (WNDW)

Winston Small Cap, Zacks, Spotlight Growth, Stock Oodles, Stock Gumshoe, Barchart, The Street, InvestorsHub, Capital Cube, AllPennyStocks, TopPennyStockMovers, Simply Wall St, SmallCapVoice, and Stockopedia reported earlier on SolarWindow Technologies, Inc. (WNDW), and we also report on the Company, here at the QualityStocks Daily Newsletter.

SolarWindow Technologies, Inc. is a developer of next generation, transparent, electricity-generating SolarWindow™ coatings. The Company is a developer of electricity-generating windows for tall towers and skyscrapers. SolarWindow™ uses organic materials dissolved into liquid, best for low-cost high-output manufacturing. SolarWindow Technologies is based in Columbia, Maryland.

The Company’s mission is to create SolarWindow™ products that produce considerable amounts of clean electricity, financially reward its customers, and benefit the environment. Upon application to glass or plastics, the coatings convert passive windows and other materials into electricity generators under natural, artificial, low, shaded, and reflected light conditions.

SolarWindow™ systems can undergo installation on the readily-available sizeable window glass surfaces on tall towers and skyscrapers. SolarWindow™ can be applied to the sides of tall towers, producing electricity using natural, shaded, and artificial light. The coatings generate electricity on see-through glass and flexible plastics with colored tints popular to skyscraper glass.
SolarWindow™ technology has been independently validated to generate 50-times the power of a conventional rooftop solar system. Additionally, it realizes a one-year payback when modeled on a 50-story building. SolarWindow™ products are undergoing development to be installed on all four sides of a skyscraper. This turns the whole building into a power generator.

SolarWindow Technologies latest products will be engineered as transparent, tinted, flexible veneers that installers can apply directly over top of existing windows on tall towers and skyscrapers. This expanded product line extends the Company’s market reach beyond new and replacement installations, to include windows now installed on the estimated five million commercial buildings built in the United States alone.

The Company entered Phase III of its Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL). The main development objective of the Agreement is the commercialization of SolarWindow™ products. Moreover, SolarWindow™ is expanding product development to include applying its electricity-generating coatings onto flexible glass – as thin as a business card (only 0.1-millimeter-thick), which is flexible enough to be bent without breaking or cracking.

In June 2018, SolarWindow Technologies announced its latest commercial alliance with nTact, an international leader in coating process knowledge and equipment manufacturing, necessary for large-scale production of transparent electricity-generating windows. To enable commercial production, SolarWindow first partnered with Triview Glass Industries, a glass fabrication plant, where its coatings can be applied to windows.

SolarWindow then entered into a collaboration with Raynergy Tek to ensure a steady supply of raw materials used in its coatings. Raynergy Tek is a chemicals developer.

The alliance with nTact provides specialty-coatings machinery required for use in a high-volume SolarWindow production line at the plant. SolarWindow Technologies scientists and engineers will work with nTact to design, prototype, test, and manufacture machinery and equipment required for coating glass and flexible materials with the Company’s transparent electricity-generating coatings that will be used to create a manufacturing line, with the aim of implementing large-scale production of SolarWindow™ electricity-generating glass and flexible products.

SolarWindow Technologies, Inc. (WNDW), closed Monday's trading session at $1.80, up 0.56%, on 16,841 volume with 68 trades. The average volume for the last 3 months is 46,296 and the stock's 52-week low/high is $1.50/$10.50.


First Foods Group, Inc. (FIFG)

OTC Markets, TradingView, Stockhouse, YCharts, and MarketWatch reported on First Foods Group, Inc. (FIFG), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

First Foods Group, Inc. has growing interests in the food and food service industry. The Company provides management services and financing options for new foodservice brands and menu concepts. In addition, it is growing its new concepts by way of proprietary development and via mergers, acquisitions, and licensing arrangements.

The Company previously went by the name Litera Group, Inc. It changed its corporate name to First Foods Group, Inc. in February of 2017. First Foods Group is headquartered in Las Vegas, Nevada.

The Company earlier signed cannabis business expert Mr. Robert Hunt, Esq. to identify opportunities in the legal cannabis industry where First Foods' management, expertise, and relationships could have significant effect. Mr. Hunt is one of the distinguished consultants in the legalized marijuana industry. He has been instrumental in many of the best known and most successful cannabis businesses in operation today.

First Foods Group entered into a binding term sheet in April 2017 with internationally renowned chocolatier and entrepreneur Mr. Oded Brenner. This is to fully develop Mr. Brenner’s new chocolate-based retail concept.

This venture is jointly owned by First Foods Group and Mr. Brenner. Initial plans are to launch two flagship stores in New York, New York, as well as to immediately leverage manifold multi-unit global franchising opportunities.

Holy Cacao is marketing premium chocolate products created and packaged by Holy Cacao consultant, Mr. Oded Brenner, founder of "Max Brenner, Chocolate by the Bald Man," for the legal cannabis sector. Mr. Brenner has incorporated an exotic mix of champagnes, sherries, and select cannabis strains into his chocolate formulas. Among the lines scheduled for production are "Lips", "Body and Soul", "Something About You and Me", and "Shooting High."

First Foods Group registered its Holy Cacao® subsidiary with the State of Nevada on August 31, 2017. Moreover, it officially finalized its brand, logo, packaging, and 7 proposed products, completing its design and concept phase. First Foods Group states that Holy Cacao will soon be licensed as a THC product in the legal marijuana states.

First Foods Funding invests in short-term merchant cash advances, which have been producing immediate high rates of return on capital. This Division continues to realize fast growth via the reinvestment of its profits while attracting significant new funds from outside investors.

Recently, First Foods Group provided an update concerning the achievement of its 7-figure capital milestone. As of April 18, 2018, it has put to work $400,000 of related party debt financing, $365,000 of unrelated party equity financing, and more than $235,000 of income and deferred revenue derived from its growing merchant cash advance business. Up until very recently in its relatively short history, First Foods Group was solely self-funded. However, it has now secured several six-figure investors.

First Foods Group, Inc. (FIFG), closed Monday's trading session at $0.16, up 58.42%, on 10,100 volume with 4 trades. The average volume for the last 3 months is 22,676 and the stock's 52-week low/high is $0.0401/$0.99.


AltiGen Communications, Inc. (ATGN)

OTC Markets, Zacks, MarketWatch, and Marketbeat reported on AltiGen Communications, Inc. (ATGN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AltiGen Communications, Inc. is a provider of Hosted Skype for Business and Contact Center solutions. The Company is a leading Microsoft Cloud Solutions provider. It delivers fully managed Unified Communications services, combining Hosted Skype for Business, Advanced Cloud PBX, and Innovative Cloud Contact Center applications with seamless integration to Office 365. OTCQB-listed, AltiGen Communications is based in San Jose, California.

The design of AltiGen’s solutions is for high reliability, user-friendliness, and seamless integration to Microsoft infrastructure technologies. The Company’s solutions are built on a scalable, open standards platform.

AltiGen Communications’ Cloud Unified Communications solution significantly simplifies deployment and management. This is while enabling SMBs and enterprises to substantially reduce costs and lower total cost of ownership. The Company’s all-software solution provides businesses the flexibility to deploy on-premises, in the Cloud, or in a hybrid environment.

AltiGen’s unique and feature rich Cloud PBX and Multi-Channel Contact Center solutions natively integrate with Skype for Business and Office 365. This is to deliver business-critical functionalities required by SMBs (Small and Midsize Businesses) and enterprises.

The Company’s MaxUC is an innovative new Unified Communications solution. It combines AltiGen’s MaxCS IP PBX with Microsoft’s Skype for Business. In addition, AltiGen has its MaxCS SIP Trunk. The SIP Trunk Service is an enterprise grade VoIP service optimized for AltiGen Communications solutions.

Furthermore, AltiGen has its Enterprise Cloud PBX. This is a total Cloud-based enterprise-wide PBX and Contact Center solution for Office 365, based on the Company’s Hosted Skype for Business, integrated with its MaxACD advanced communications application set.

AltiGen also has its MaxACD Cloud. MaxACD enhances Skype for Business and Office 365 with Cloud-based Automated Multimedia Routing and Queuing capabilities to address the Enterprise “Line of Business” requirements for Internal or External customer requests.

This past April, AltiGen Communications announced its financial results for Q2 ended March 31, 2018. Financial highlights for the quarter include Revenue of $2.5 million. This represents a 21 percent increase over the year-ago Q2. Net Income was $383,000 GAAP (Generally Accepted Accounting Principles), and $390,000 non-GAAP.

For the six months, Revenue was $4.8 million. This represents a 15 percent increase over the previous year. Net Income was $721,000 GAAP, and $733,000 non-GAAP.

AltiGen Communications, Inc. (ATGN), closed Monday's trading session at $0.5186, up 3.72%, on 134,712 volume with 18 trades. The average volume for the last 3 months is 11,365 and the stock's 52-week low/high is $0.25/$0.64.


Generex Biotechnology Corporation (GNBT)

Hotstocked, Trader Planet, Market Screener, YCharts, Zacks, StockAnalyst24, Insider Financial, MicroCap Daily, Capital Cube, InvestorsHub, StreetInsider, BioCentury, Stockhouse, Annual Reports, and OTC Markets reported on Generex Biotechnology Corporation (GNBT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Generex Biotechnology Corporation engages in the discovery, research, development, and financing of new compounds, therapies, diagnostics, delivery systems, and medical technologies. Its chief focus has been its proprietary technology for the administration of formulations of large molecule drugs to the oral (buccal) cavity using a handheld aerosol applicator. A biopharmaceutical business, Generex Biotechnology has offices in Miramar, Florida, and Burlington, Ontario. Sometime in 2018, Generex Biotechnology will have a new name - NuGenerex Life Sciences Holdings, Inc. (NuGenerex).

The Company has two business focuses. One is implementing an acquisition strategy. The second is financing sponsored clinical trials. Generex Biotechnology is positioning its business as a diversified holding company involved in growing its pipeline of compounds, therapies, treatments, diagnostics, and technologies in all stages in the Food and Drug Administration (FDA) process via accretive acquisitions.

Antigen Express, Inc. is a wholly-owned subsidiary of Generex Biotechnology. Antigen Express is a platform and product-based company developing proprietary vaccine formulations for large, unmet medical needs. Antigen’s emphasis is on stimulating vital members of the immune response, called T helper cells.

Generex Biotechnology’s Generex Oral-lyn is an insulin spray for the treatment of Type I and Type II diabetes. The Company states that Generex Oral-lyn is a safe, simple, fast, effective, and pain-free alternative to subcutaneous injections of prandial insulin. It is conveniently delivered to the membranes of the oral cavity through a simple asthma-like device with no pulmonary (lung) deposition.

Generex Biotechnology announced in July 2018 the filing of a patent for its new Diagnostic Point-of-Care Platform, the Express II. Hema Diagnostic Systems, LLC d/b/a NuGenerex Diagnostics, a subsidiary of Generex Biotechnology, announced the filing of a patent on its new diagnostic qualitative point-of-care platform, the Express II.

The design of the Express II is to be used in professional medical settings and for direct home use by consumers. It can be used for the detection of a wide array of analytes in whole blood samples obtained by a simple finger stick, or with plasma or serum samples in clinical laboratories.

In September, Generex Biotechnology announced the launch of NuGenerex Medical Marketing (NMM). Generex is establishing NMM as an integrated sales and marketing backbone to support the earlier announced plan to establish Generex as a presence in the U.S. direct-to-consumer pharmaceuticals business by way of a multi-channel acquisition strategy. NMM will provide in-depth patient health management services. Services will include patient identification, acquisition and onboarding, and also ongoing patient support services for chronic care management via a dedicated call-center.

Earlier in October, Generex Biotechnology announced that it, in combination with its research collaborators Merck and the NSABP Foundation, will file an IND this month to initiate A Phase II Clinical Trial of Pembrolizumab (Keytruda®) in Combination with the AE37 Peptide Vaccine in Patients with Metastatic Triple Negative Breast Cancer. The anticipation is that this trial will initiate sites in Q4 and commence enrolling patients in Q1 2019. AE37 is also undergoing development for the treatment of prostate cancer by Generex’s partner, Shenzhen Bioscien.

Last week, Generex Biotechnology announced that Mr. Anthony S. Crisci, Esq., CPA joined Generex as the General Manager, Chief Compliance Officer & Corporate Counsel for all of NuGenerex’s distribution efforts, including its newly acquired eight pharmacies and laboratory from Veneto Holdings, L.L.C., to lead the Company in building an end-to-end solution for pharmacy and health management services. Mr. Crisci is a member of the New York and New Jersey Bar associations, and also a licensed CPA.

Generex Biotechnology Corporation (GNBT), closed Monday's trading session at $11.00, up 57.14%, on 37,685 volume with 298 trades. The average volume for the last 3 months is 3,590 and the stock's 52-week low/high is $1.76/$8.35.


Aphria, Inc. (APHQF)

Stock Twits, Marketwired, Investor Place, Pot Network, YCharts, Profit Confidential, Market Realist, Morningstar, Midas Letter, CFN Media Group, Finance Registrar, and Cannabis Financial Network News reported previously on Aphria, Inc. (APHQF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Aphria, Inc. is one of Canada’s lowest cost producers that produces, supplies, as well as sells medical cannabis. The Company’s medical cannabis products are 100 percent greenhouse grown. Aphria works to provide pharmaceutical-grade medical cannabis and first-class patient care. Its commitment is to do this while balancing patient economics and returns to shareholders. Listed on the OTC Markets, Aphria has its is headquartered in Leamington, Ontario.

Aphria will rename its earlier-acquired subsidiary Nuuvera as Aphria International, remaining as a wholly-owned subsidiary of Aphria. Aphria International will center its activities on established regulated cannabis markets globally. This includes where Aphria International already has major interests.

Aphria is a Health Canada Licensed Producer of medical cannabis products. Its cannabis oil products are produced using C02 extraction methods. These methods preserve purity and ensure safety. Aphria’s equivalency factor of cannabis oil to dried cannabis is 6:1.Therefore, every 6 mL of cannabis oil is equivalent to 1 gram of dried cannabis.

Aphria is in the middle of a multi-phase expansion program. Upon completion of Part II, it expects that annual production capacity will reach 5,500 kilograms of dried cannabis and 9,000 liters of cannabis oil.

Aphria announced in late September, that it closed the acquisition of LATAM Holdings from Scythian Biosciences. This Transaction was underwritten by the assumption of US$1 million of existing LATAM Holdings debt with the remaining consideration underwritten by the issuance of 15,678,310 common shares of Aphria. The closing was pursuant to the terms of the definitive share purchase agreement earlier announced by Aphria on July 17, 2018.

Mr. Vic Neufeld, Chief Executive Officer of Aphria, said, "Aphria continues to execute on its plans for strategic international expansion, including in Latin America and the Caribbean… This acquisition firmly cements Aphria's leadership in the region and on the global cannabis stage."

With this agreement, Aphria acquired a 90 percent ownership interest in Colcanna S.A.S. Colcanna is the first company in the Coffee Zone of Colombia with cultivation and manufacturing licenses for the production of medicinal extracts of cannabis.

Aphria also acquired ABP, S.A. ABP is an established and successful pharmaceutical import and distribution company in Argentina. Furthermore, Aphria acquired a 49 percent ownership interest in Marigold Projects Jamaica Limited, and a right of first offer and refusal regarding a majority interest in a Brazilian entity, upon the receipt of a license, in the entity receiving the license.

Aphria, Inc. (APHQF), closed Monday's trading session at $15.35, up 4.78%, on 2,509,681 volume with 9,223 trades. The average volume for the last 3 months is 1,995,370 and the stock's 52-week low/high is $5.068/$19.869.


Propanc Biopharma, Inc. (PPCB)

InvestorsHub and Investing News reported on Propanc Biopharma, Inc. (PPCB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Propanc Biopharma, Inc. is a clinical stage Biopharmaceutical Company listed on the OTCQB. It focuses on the development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian, and colorectal cancers. The Company has developed a formulation of anti-cancer compounds that exert numerous effects designed to control or prevent tumors from recurring and spreading throughout the body. Propanc Biopharma has its head office in Australia.

The Company is developing a long-term therapy founded on a pancreatic proenzyme formulation to prevent tumour recurrence and metastasis. Its lead product is PRP. This is a novel, patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is a solution for once daily intravenous administration of a combination of two pancreatic proenzymes, trypsinogen and chymotrypsinogen, for the treatment of pancreatic cancer.

Propanc Biopharma has received Orphan Drug Designation (ODD) from the Food and Drug Administration (FDA) for the use of PRP. The approved indication is one of the most lethal malignancies with a median survival of 6 months and a 5-year survival rate of less than 5 percent.

Propanc (after extensive laboratory research and a limited amount of human testing) has evidence that PRP lessen cancer cell growth through promotion of cell differentiation; enhances cell adhesion, and may suppress metastasis progression; and has no serious side effects and improves patient survival.

Development progress for PRP includes successful completion of a GLP-compliant, 28-day repeat-dose toxicity study with no toxicological findings after administration. This indicates a broad safety margin. It provides sufficient data to support a safe starting dose for First-In-Human studies.

Additionally, a manufacturing process capable of purifying and stabilizing two active drug substances of the PRP formulation, trypsinogen and chymotrypsinogen were successfully developed. Furthermore, the FDA granted Orphan Drug Designation status to PRP for the treatment of pancreatic cancer.

This past March, Propanc Biopharma announced the successful reproduction run of the manufacturing process for its two drug substances trypsinogen and chymotrypsinogen. The successful reproduction run demonstrates scalability of the Company's proprietary manufacturing process to enable routine production of the two active substances for Propanc’s lead product candidate, PRP. The process was developed in collaboration with a European Contract Manufacturing Organization (CMO) experienced in the production of biopharmaceuticals.

Recently, Propanc Biopharma announced the completion of a scientific advice meeting with the Medicines and Healthcare Products Regulatory Agency (MHRA), UK, pertaining to the investigational medicinal product (IMP) manufacturing program for PRP. Several topics were raised and clarified concerning the preparation of a clinical trial application (CTA) for a First-In-Human study in the UK.

Important topics included the definition of starting material under Good Manufacturing Practice (GMP) principles and certain tests to be conducted as part of the continuing quality assurance and control requirements for manufacture of a biological product for human use.

Propanc Biopharma, Inc. (PPCB), closed Monday's trading session at $0.077325, up 10.46%, on 6,880,335 volume with 547 trades. The average volume for the last 3 months is 10,714,412 and the stock's 52-week low/high is $0.0039/$0.77.


Lucara Diamond Corp. (LUCRF)

InvestorPoint, Insider Financial, Stockhouse, CapitalCube, MarketWatch, The Street, 4-Traders, Penny Stock Tweets, Dividend Investor, Mining Feeds, Barchart, Marketbeat, ProInvestor, Investors Hangout, Stockwatch, Wallmine, and InvestorsHub reported on Lucara Diamond Corp. (LUCRF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Lucara Diamond Corp. is a diamond mining company engaging in the acquisition, exploration, development, and operation of diamond properties in Africa. Lucara is a leading independent producer of large exceptional quality Type IIa diamonds from its 100 percent owned Karowe Mine in Botswana. The Company is a member of the Lundin Group of Companies. Lucara Diamond is headquartered in Vancouver, British Columbia.

The Karowe Diamond Mine in Botswana has been in production since 2012. It is one of worlds' leading producers of large, Type IIA diamonds in excess of 10.8 carats. This includes the historic 1,109 carat Lesedi La Rona (second largest gem diamond ever recovered) and the 813 carat Constellation (sold for a record US$63.1 million).

From the Karowe Diamond Mine 158 diamonds have sold for more than US$1 million each (total value in excess of US$600 M). A PFS is taking place on Karowe underground with the potential to extend the mine-life to 2036.

Lucara Diamond announced in April of this year the recovery of a 327 carat, top white gem diamond from its Karowe Diamond Mine in Botswana.  Eight diamonds greater than 100 carats have now been recovered at the Karowe Diamond Mine since the beginning of 2018. This includes the 472 carat diamond announced earlier in April.

In addition, Lucara Diamond has its 100 percent owned Clara Diamond Solutions Corp. On March 2, 2018, Lucara Diamond announced that it closed its acquisition of Clara Diamond Solutions. This is a secure, digital sales platform. It employs proprietary analytics together with cloud and blockchain technologies to modernize the existing diamond supply chain, boosting efficiencies, unlocking value and ensuring diamond origin from mine to finger.

Historically, Lucara Diamond has held Regular Stone Tenders (RSTs) and Exceptional Stone Tenders (ESTs). RSTs represent the majority of the Company’s run of mine production, held about 4 times annually.

This past August, Lucara Diamond announced that Clara Diamond Solutions entered into a Collaboration Agreement with Sarine Technologies Ltd. Clara will be the exclusive, international customer for customized interfaces and versions of Sarine's Galaxy® inclusion mapping technology and its Advisor® optimal rough planning for use with Clara's 100 percent owned, proprietary digital diamond sales platform. Clara is on course to launch in 2018, with inaugural rough diamond sales set to begin in Q3. Clara Diamond Solutions is the world's foremost developer of technologies for the diamond industry.  

Lucara Diamond Corp. (LUCRF), closed Monday's trading session at $1.6502, down 1.08%, on 11,186 volume with 8 trades. The average volume for the last 3 months is 30,628 and the stock's 52-week low/high is $1.51/$2.325.


TechPrecision Corp. (TPCS)

Stock Rich, FeedBlitz, SmallCapVoice, BullRally, HotOTC, CoolPennyStocks, PennyStockVille, MadPennyStocks, Marketbeat, TopPennyStockMovers, Zacks, StreetInsider, Energy and Capital, Wealth Daily, and Stock Market News Alert reported earlier on TechPrecision Corp. (TPCS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

TechPrecision Corp., by way of its wholly-owned subsidiaries, Wuxi Critical Mechanical Components Co., Ltd., and Ranor, Inc., is an industry leading manufacturer of precision, large-scale fabricated and machined metal components and tested systems. The Company’s aim is to be an end-to-end worldwide service provider to its customers through furnishing customized and integrated turn-key solutions for completed products requiring custom fabrication and machining, assembly, inspection, and testing.

TechPrecision has its head office in Westminster, Massachusetts. Its subsidiary companies have facilities in the United States and China. The Company’s shares trade on the OTC Markets Group’s OTCQB.

TechPrecision’s products are used in the alternative energy, medical, nuclear, defense, and precision industrial, aerospace, and naval/maritime markets, among others. TechPrecision has the fabrication capacity to see a client’s large-scale components through from initial processing to final finishing and assembly. This eliminates the need for outside servicing. Moreover, it helps ensure lower costs.

The design of TechPrecision’s Wuxi Critical Mechanical Components (CMC) subsidiary is to meet the increasing international demand for an experienced, knowledgeable machining and distribution center in Asia, providing large-scale component fabrication solutions for the region's wind power and solar challenges.

CMC uses one of the largest forges in the industry. CMC’s capabilities include Forging; Fabrication; Machining; Inspection; Assembly & Finishing, and Quality Assurance. CMC serves the Solar/LED; Wind; Nuclear; Clean Technology, Medical; as well as General Industrial industries.

TechPrecision’s Ranor subsidiary specializes in large-scale, precision component fabrication for the Clean Technology, Energy, Medical, Aerospace, and Defense sectors. Ranor’s capabilities cover Production Control; Engineering; Processing; Fabrication; Machining; Assembly & Finishing; Quality Assurance, and NDE & Inspection.

Yesterday, TechPrecision announced it will release financial results for its 2018 Fiscal Q4 and Year End on Thursday, June 28, 2018. The Company will hold a conference call at 4:30 p.m. Eastern (U.S.) Time on that day.

TechPrecision Corp. (TPCS), closed Monday's trading session at $0.89, up 4.71%, on 30,169 volume with 19 trades. The average volume for the last 3 months is 28,865 and the stock's 52-week low/high is $0.46/$0.86.


Goldsource Mines, Inc. (GXSFF)

Stockhouse, Street Insider, Barchart, Mining Stock Valuator, MarketWatch, The Prospector News, 4-Traders, WalletInvestor, Resource World, TipRanks, Marketbeat, Investors Hangout, OTC Markets, The Stock Market Watch, and Geology for Investors reported on Goldsource Mines, Inc. (GXSFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Goldsource Mines, Inc. is a resource enterprise now in the Proof of Concept Phase at its 100 percent-owned Eagle Mountain Gold Project in Guyana, South Africa. The Company’s vision at Eagle Mountain is to support a large-scale open pit gravity/CIL gold operation, centered on low strip ratio, low cost mining of Eagle Mountain’s surficial saprolite resources. Goldsource Mines has its corporate headquarters in Vancouver, British Columbia.

The Eagle Mountain Gold Project is roughly 200 km southwest of Guyana’s capital, Georgetown. It is 45 km from the historic Omai Gold Mine. At Eagle Mountain, Goldsource Mines built in 2015, and operated in 2016, a 1,000 t/d gravity pilot processing plant. A Pre-Feasibility Study (PFS) for a gravity/cyanidation medium size operation is in progress.

Goldsource Mines also has its Border Property in the Province of Saskatchewan. The Border Property is the focus of a major coal discovery in 2008. This property is on the eastern edge of mining-friendly central Saskatchewan, approximately 50 kilometers north of the town of Hudson Bay. The Border Property comprises roughly 16,073 hectares. It is along the Durango Coal Trend that continues to the southeast and northwest of the property.

This past April, Goldsource Mines announced that on March 29, 2018, the Company, via its subsidiary and with its local joint venture partner in Guyana, Kilroy Mining, Inc., executed a definitive agreement with a local Guyanese individual for the option to explore and purchase a 100 percent interest in the Bishop Growler Property.

Bishop Growler is positioned along the projected mineralized trend three kilometers from Goldsource Mines’ Eagle Mountain Gold Project in Guyana, South America. It is surrounded by Eagle Mountain's existing 5,030-hectare Prospecting License (EMPL).

In May, Goldsource Mines announced positive metallurgical test results on its continuing saprolite expansion program at its Eagle Mountain Gold Project. In addition to ongoing drilling and trenching at Eagle Mountain, Goldsource is progressing on metallurgical test work. This includes grinding cost-benefit analysis studies.

Moreover, in May, Goldsource Mines announced a new discovery and further positive results on its ongoing saprolite exploration program at its Eagle Mountain Gold Project. The new discovery, "Salbora" area, is about 1.5 kilometers northwest of the Eagle Mountain deposit.

Through diamond drilling, Goldsource also received positive results on an earlier announced expansion target, "Friendly" area, situated at the northern edge of the Eagle Mountain deposit. The most significant result for this release was returned from Trench TRSB18-002 at the Salbora Area, which intersected 123 meters (horizontal width) grading 1.92 grams per tonne (gpt) gold.

Goldsource Mines, Inc. (GXSFF), closed Monday's trading session at $0.057, up 3.64%, on 105,417 volume with 7 trades. The average volume for the last 3 months is 82,839 and the stock's 52-week low/high is $0.029/$0.095.


AEON Global Health Corp. (AGHC)

Amigo Bulls, Stockopedia, Penny Stock Hub, Stockwatch, Simply Wall St, Zacks, Stockflare, Dividend Investor, Stockhouse, InvestorsHub, YCharts, TradingView, The Street, Stock Target Advisor, and Investors Hangout reported on AEON Global Health Corp. (AGHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

AEON Global Health Corp., together with its subsidiaries, provides a variety of clinical laboratory testing services in the United States. The Company offers diagnostic services in Cancer Genomics, Toxicology, Pharmacogenomics, and Health Technology Applications. The Company formerly went by the name Authentidate Holding Corp. It changed its name to AEON Global Health Corp. in January 2018. AEON Global Health is headquartered in Gainesville, Georgia.

AEON is the fastest growing clinical lab and healthcare services organization in the U.S. It is first in healthcare technology research and development (R&D) where its proprietary methodologies provide expedited and highly accurate urine and oral fluid (saliva) test results.

Essentially, AEON Global Health’s primary business focus is providing a “personalized medicine” approach to laboratory testing services. This is to provide customers with actionable medical information.

AEON is an innovator in the genomic testing area. The Company has an extensive menu of genetic tests and a pipeline of additional molecular-based tests in development. AEON Global Health provides post contract customer support services.

AEON Clinical Labs services include Cancer Genomics, Pharmacogenomics, Toxicology, and Women’s Health. Health Technologies services include Inscrybe®. This is a secure and simple interface. Inscrybe® allows physicians, nurses, hospital staff, and external care facilities or health insurers to send, receive, sign, and track healthcare records, supporting documents, patient discharge orders and referrals or lab results and images on the web or via electronic fax instead of transferring paper.

The design of AEON’s Telehealth Solutions is to improve outcomes and reduce hospital readmission through helping clinicians closely monitor patients with chronic illnesses such as CHF, COPD and Diabetes.

AEON Global Health has agreed with Sabal Therapeutics, LLC to be the principal laboratory marketer of Naprosyn®, the branded naproxen oral suspension USP. Under the agreement, AEON Global Health will become the exclusive clinical laboratory marketing representative of Sabal Therapeutics. It will market the drug alongside of its industry-leading drug monitoring service.

Last month, AEON Global Health announced that it earned The Joint Commission's Gold Seal of Approval® for Laboratory Services Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal of Approval is a symbol of quality, which reflects an organization's commitment to providing safe and effective patient care.

Sonny Roshan, Founder, Chairman and Chief Executive Officer of Aeon Global Health, said, "We are proud that the Joint Commission has provided our laboratory with this prestigious certification. This award reflects our unwavering commitment to maintaining the highest quality of standards in all areas of our operations."

AEON Global Health Corp. (AGHC), closed Monday's trading session at $0.825, up 3.77%, on 4,000 volume with 5 trades. The average volume for the last 3 months is 4,484 and the stock's 52-week low/high is $0.40/$1.65.


UEX Corporation (UEXCF)

OTC Markets, Stockhouse,, Barchart, Geology for Investors, Investing News, Wolcott Daily, Morningstar, Stockwatch, MarketWatch, Barron’s, Junior Mining Network, and OTC Dynamics reported on UEX Corporation (UEXCF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

UEX Corporation is a junior exploration company with a diverse portfolio of projects in Saskatchewan’s Athabasca Basin. Since its establishment, the Company has made significant advancements in the discovery and development of existing and new uranium deposits in the Athabasca Basin. UEX has its head office in Saskatoon, Saskatchewan. The Company also has a satellite office in Vancouver, British Columbia.

UEX’s foundation is substantial existing uranium resources. Furthermore, the Company is exploring the West Bear Cobalt-Nickel Prospect by way of its 100 percent owned subsidiary CoEx Metals Corporation. The West Bear Project was formerly part of UEX’s Hidden Bay Project. It contains the West Bear Cobalt-Nickel Prospect and the West Bear Uranium Deposit.

Additionally, UEX is increasing its resources at Christie Lake. The new Orora Discovery tested the Company’s first identified new target on this project. On the whole, UEX has a large inventory of historical mineralized holes that can undergo follow up to make new discoveries. In essence, the Company’s focus is on growing Christie Lake Uranium and enhancing Shareholder value through Cobalt.

UEX is involved in 17 uranium projects, including seven that are 100 percent owned and operated by the Company, one joint venture (JV) with Orano Canada, Inc. that is 90.1 percent owned by UEX and is under option to and operated by ALX Uranium, and eight JVs with Orano, one JV with Orano and JCU (Canada) Exploration Company Limited, which are operated by Orano, and one project (Christie Lake) under option from JCU (Canada) Exploration Company Limited and operated by UEX.

UEX is now advancing several uranium deposits in the Athabasca Basin. These include the Christie Lake deposits, the Kianna, Anne, Colette and 58B deposits at its currently 49.1 percent-owned Shea Creek Project, the Horseshoe and Raven deposits on its 100 percent-owned Horseshoe-Raven Development Project, and the West Bear Uranium Deposit positioned on its 100 percent-owned West Bear Project.

In early May, UEX, via CoEX Metals, announced that the fourth tranche of assay results were received for the final 15 holes from the Phase 1 winter drilling program on the West Bear Cobalt-Nickel Prospect. The Company completed 41 holes totaling 4,457 m on its West Bear Cobalt-Nickel Prospect situated on the West Bear Project with the aim of expanding the size of the cobalt and nickel mineralized zone.  Phase 1 drilling activities at West Bear have now concluded.

UEX Corporation (UEXCF), closed Monday's trading session at $0.1482, up 2.21%, on 119,473 volume with 30 trades. The average volume for the last 3 months is 39,973 and the stock's 52-week low/high is $0.1116/$0.313.


Planet 13 Holdings Incorporation (PLNHF)

Wallet Investor, Penny Stock Hub, Markets and Research, InvestorX, MicroSmallCap, Market Screener, Stockhouse, MarketWatch, Dividend Investor, TradingView, Morningstar, Financial Content, MicroCap Daily, InvestorsHub, and Pot Network reported on Planet 13 Holdings Incorporation (PLNHF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Planet 13 Holdings Incorporation is a vertically integrated cannabis company listed on the OTC Markets Group’s OTCQB. Planet 13 has award-winning cultivation, production and dispensary operations in Las Vegas, Nevada. The Company is a vertically-integrated and established cannabis leader in the Nevada market. Planet 13’s emphasis is on providing a premier dispensary experience and optimizing cultivation efficiencies via its best-in-class technology, as the frontline of cannabis. Planet 13 is headquartered in Las Vegas.

On September 17, 2018, Planet 13 Holdings announced that the OTC Markets Group approved the listing of the Company's common shares on the OTCQB Venture Market under the ticker symbol "PLNHF". Trading commenced on the OTCQB at the opening of the market on Monday, September 17, 2018.

The Company’s mission is to build a recognizable international brand known for world class dispensary operations, and a creator of unique cannabis products. On November 1, 2018, Planet 13 is opening the largest, most advanced retail dispensary globally immediately adjacent to the Las Vegas strip. The new facility will feature 16,200 sq. ft. of dispensary space.

The new superstore has a sophisticated outdoor water feature and huge interactive electric lotus flowers on the roof visible from 65,000 hotel rooms, which overlook the location. Once inside, an enormous interactive LED floor, laser graffiti walls, and overhead aerial orbs circling every hour will continue to engage customers.

Planet 13 has 6-plus Cannabis Licenses. It is fully licensed for cultivation, retail distribution and more in the fast developing Nevada market. The Company’s Medizin dispensaries provide premier quality recreational cannabis, cannabis extracts, and infused products. Medizin also focuses on industry-leading customer experiences. Medizin produces flower, concentrates, vape pens, edibles and more. Medizin (Medical) and Planet 13 (Recreational) brands are already some of the most awarded cannabis product brands in Nevada.

Planet 13 Holdings will be speaking at two prominent cannabis industry events. Planet 13 Chief Financial Officer (CFO), Mr. Dennis Logan, will be presenting at the Canaccord Genuity U.S. Cannabis Symposium at 11:30 AM on October 18, 2018 in Toronto, Ontario at the Sheraton Centre Toronto Hotel.

Planet 13 Co-CEO, Mr. Bob Groesbeck, will take part in a panel discussion at The Institutional Capital & Cannabis Conference (IC3) discussing Canada versus the U.S. at 12:05 PM on October 22, 2018 in New York.

Planet 13 Holdings Incorporation (PLNHF), closed Monday's trading session at $2.0117, down 0.90%, on 201,982 volume with 314 trades. The average volume for the last 3 months is 126,887 and the stock's 52-week low/high is $0.502/$2.38.


The QualityStocks Company Corner

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI) continues to grow its HempFX line with the scheduled November introduction of two new products: ‘HempFX Hydration – Pure’ and ‘HempFX Hydration – Sleep’. These are tablet-based products that utilize the company’s Y-DR8+ proprietary technology ( Also today, Research Driven Investing initiated coverage on the company Also today, CannabisNewsWire released an Audio Press Release (APR) titled “CBD Exploding into Mainstream Wellness Products,” featuring Youngevity. To hear the CannabisNewsAudio version, visit: To read the full editorial, visit:

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $15.88, up 19.40%, on 4,485,177 volume with 22,280 trades. The average volume for the last 3 months is 322,989 and the stock's 52-week low/high is $3.167/$14.39.

Recent News


Canopy Rivers Inc. (TSX.V: RIV)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV).

Canopy Rivers Inc. (TSXV:RIV) is pleased to announce PharmHouse Inc. (“PharmHouse”), has entered into an offtake agreement (the “Agreement”) to supply TerrAscend Canada Inc. (“TerrAscend Canada”), a wholly-owned subsidiary of TerrAscend Corp. (“TerrAscend”) (CSE:TER),  with cannabis products from 20% of the flowering space at its 1.3 million square foot greenhouse facility until December 31, 2021. Also today, Bruce Linton, Acting CEO, Director, and Chairman of Canopy Rivers opened the market. Canopy Rivers is an investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers Inc. commenced trading on TSX Venture Exchange on September 20, 2018.

Canopy Rivers Inc. (TSX.V: RIV) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $6.03, up 5.79%, on 2,212,493 volume with 2,786 trades. The average volume for the last 3 months is 34,623 and the stock's 52-week low/high is $3.1877/$11.82.

Recent News



The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC: NUGL) (the “Company”), the cannabis industry's new standard of technology, today reports it has entered into a binding letter of intent (“LOI”) to purchase Nichols Publishing Company , Inc. (“Nichols Publishing”), an Iowa based corporation that publishes industry known magazine publications such as the Professional Marijuana Grower and Garden & Greenhouse. Also today, NetworkNewsWire released a report on the company detailing how is poised to deliver even more options to the 420 community with a major update to its popular iOS app, available on the Apple Store, and its Android app, available on Google Play. True to the company’s word, the update reflects the wants, needs and desires of the cannabis community that it seeks to serve, as Ryan Bartlette, CMO of NUGL, stated in a news release (

NUGL Inc. (NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $2.32, up 6.91%, on 186,930 volume with 279 trades. The average volume for the last 3 months is 192,775 and the stock's 52-week low/high is $0.405/$2.64.

Recent News


DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company (“DPW”), announced that a group which includes DPW as an investor secured an $85 million construction loan commitment from a New York City-based multinational investment bank for the construction of a five-star ultra-luxury hotel in Tribeca (the “Hotel”). and led by two New York real estate development companies, Mactaggart Family & Partners LP and Caspi Development, As announced on May 25, 2018, DPW Holdings acquired a minority position in the investment.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.3541, up 2.28%, on 2,878,832 volume with 3,637 trades. The average volume for the last 3 months is 1,767,543 and the stock's 52-week low/high is $0.3059/$5.949.

Recent News


Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Traders News Source, a leading independent equity research, and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Phivida Holdings Inc. (OTCQX: PHVAF). The company purchases packages and sells holistic hemp infused products. The company is also a supplier of hemp oil extracts, targeting manufacturers of consumer-packaged products, cosmetics pharmaceuticals as well as pet supplements. A review of Phivida's products, sales and recent corporate highlights in this full report READ MORE

Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.


Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.


Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.

The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

3 Wholly Owned Subsidiaries

  • Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at
  • Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
  • Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.


Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.

Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.

Strategic Agreements

Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.

Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).

Further Information
+1 (844) 744-6646 (ext. #2)

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.678, up 1.19%, on 71,458 volume with 64 trades. The average volume for the last 3 months is 104,362 and the stock's 52-week low/high is $0.05/$1.80.

Recent News


Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Next-generation energy and technology company Zenergy Brands (OTC: ZNGY) is focused on building value for its shareholders, with an innovative initiative to go virtual. A recent article discussing this reads, “Also, of course, Zenergy aims to boost its own value for investors. In July, the company announced a seven-year agreement with BitPlus, Ltd. to gain a competitive advantage in the bitcoin mining industry (, and, on October 1 the company announced the rebranding of a Texas retail electric provider (‘REP’) that it acquired earlier this year to provide ‘virtual utility’ services.” To view the full article, visit:

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0004, even for the day, on 20,095,945 volume with 22 trades. The average volume for the last 3 months is 16,541,543 and the stock's 52-week low/high is $0.0003/$0.029.

Recent News


Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (OTC: GRYN), based in Nevada, is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company’s aim is to provide medical and recreational consumers with the best possible product and experience. A full-scope, premium cannabis cultivation company, Green Hygienics is focusing on the high-end medical and adult-use recreational markets.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.38, off by 1.55%, on 3,883 volume with 5 trades. The average volume for the last 3 months is 63,770 and the stock's 52-week low/high is $0.009/$0.50.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX), developer of a proprietary financial news media and content platform providing information to the global Chinese-speaking community, this morning announced that CEO Warren Wang will be presenting live at on October 18, 2018, at 10:45 am ET. Per the update, the presentation will be a live, interactive online event in which investors will be invited to ask the company questions in real-time – both in the presentation hall and at the association’s ‘virtual trade booth’. For interested parties who are unable to attend the live event, an on-demand archive of the conference will be available for 90 days. The company recommends that investors pre-register at and run the online system check to save time and receive event updates. For more information about the presentation, visit To view the full press release, visit:

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.83, off by 2.35%, on 494,794 volume with 360 trades. The average volume for the last 3 months is 578,000 and the stock's 52-week low/high is $0.365/$1.58.

Recent News


Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (OTC: REFG), known for its state-of-the-art Green FinCEN-compliant processing system, is working from the ground up to serve the cannabis industry. The company has expanded its services to participate within the hemp and cannabis industries at strategic levels. This includes providing a proprietary, organic soil nutrient and mobile CBD extraction labs to hemp farms owned and operated by the company, as well as continuing to strengthen the Green platform, providing dispensaries with cash-free options. By managing supply and demand from seed to sale, REFG is gaining a competitive edge in the industry.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.02499, off by 5.34%, on 665,178 volume with 41 trades. The average volume for the last 3 months is 403,203 and the stock's 52-week low/high is $0.0161/$0.092.

Recent News


Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile (TSX.V: LITH) (OTCQB: LTMCF) is positioned to exploit huge opportunities for lithium producers as global demand for electric vehicles is forecasted to grow at annual rate of 15.6 percent over next five years. To view the full article, visit:

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.457, off by 8.38%, on 64,392 volume with 52 trades. The average volume for the last 3 months is 49,563 and the stock's 52-week low/high is $0.4733/$0.97.

Recent News


Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTCQB: ETST), a biotech company focused on the cannabinoid nutraceutical and pharmaceutical fields, medical devices and research and development, recently announced a detailed marketing strategy for Hygee, issued an update on CBD patents and reacted to the DEA’s shifted stance toward CBD.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $1.33, off by 12.50%, on 175,311 volume with 275 trades. The average volume for the last 3 months is 92,387 and the stock's 52-week low/high is $0.421/$2.45.

Recent News


Hunter Oil Corp. (TSX.V: HOC) (OTC: HOILF)

The QualityStocks Daily Newsletter would like to spotlight Hunter Oil Corp. (HOILF).

Hunter Oil Corp. (TSX.V: HOC) (OTC: HOILF), (“Hunter Oil” or the “Company”) is an oil and gas exploration, development and production company. The Company’s corporate headquarters are located in Vancouver, British Columbia, and its operational headquarters are in Houston, Texas. Along with its subsidiaries, Hunter Oil is engaged in acquisition, development, operation, and exploitation of crude oil and natural gas properties in the Permian Basin in eastern New Mexico. The Company owns and operates two large, proven oil fields – the Chaveroo and Milnesand San Andres fields – with a total acreage position of over 23,000 acres that are essentially contiguous. Hunter Oil’s operations involve re-accessing the existing reservoirs and developing the resource by utilizing contemporary completion techniques and proven unconventional recovery technologies.

First developed in the 1950s and 1960s using vertical well production technology, the Chaveroo and Milnesand fields produced 40 million barrels or only a fraction of the original oil in place, leaving behind significant recoverable reserves. Hunter Oil plans to unlock the value in these resource-rich fields by leveraging existing infrastructure, lowering operating costs and increasing efficiencies of its operations. By exploiting the pre-existing infrastructure at these proven, legacy assets, Hunter Oil is poised to capitalize on a significantly reduced exploration and finding cost threshold that enables profitability. Net present value of its reserves in these fields, discounted at 10 percent, is estimated at US$829.7 million as disclosed in the company’s year-end 2017 reserve report(1).

The Company’s wholly-owned subsidiary, Ridgeway Arizona Oil Corp., recently received drilling permits for five wells in its Chaveroo oil field. Hunter Oil intends to develop the Chaveroo reserves by drilling up to 84 horizontal wells. These permits represent the first group of wells to be drilled in the planned program and mark a significant milestone. During the past three years, the Company has readied the two oil fields for their next phase of exploitation via infill horizontal redevelopment.

The planned wells will target the San Andres formation at approximately 4,500’ TVD (true vertical depth) and will be one-mile-long horizontal wells. The Chaveroo oil field has reserves targeted for exploitation of 22 MMBOE (million barrels of oil equivalent) consisting of Proved Undeveloped reserves of 8.4 MMBOE, Probable reserves of 3.4 MMBOE, and Possible reserves of 10.2 MMBOE, as disclosed in the Company’s year-end 2017 reserve report(1).

Hunter Oil’s management team has decades of experience in oil production, both internationally and domestically, allowing for a greater understanding of operating assets on both state and federally regulated lands. Al H. Denson, P.E., recently appointed as Chief Executive Officer of Hunter Oil Corp., is an active member of the Society of Petroleum Engineers with more than 40 years of exploration and production experience. He began his career in 1976 with Amoco Corporation (now BP), where he served in various engineering, operational and management roles, both in the U.S. and internationally. Mr. Denson, who served as a director and member of the Company’s Operating Committee from 2014 to 2017, earned both a Bachelor’s degree and Master’s degree in Petroleum Engineering from Mississippi State University and is a Registered Professional Engineer in the State of Louisiana.

As a believer in corporate responsibility, Hunter Oil is committed to safe and responsible exploration and development practices that reflect a thoughtful awareness of the impact its operations have on the environment and community. Hunter Oil’s mission is to bring environmental, social and economic value to all of its stakeholders.

(1) This information is a summary only and readers are referred to the Company’s news release dated April 26, 2018 for further details, as well as to the evaluation of the Company’s reserves conducted by independent qualified reserves evaluator, Cawley, Gillespie & Associates, Inc., effective December 31, 2017 which is available at

Hunter Oil Corp. (HOILF), closed the day's trading session at $0.1636, up 110.01%, on 200 volume with 1 trade. The average volume for the last 3 months is 3,229 and the stock's 52-week low/high is $0.0182/$2.009.

Recent News


WhereverTV Broadcasting Corp. (TVTV)

The QualityStocks Daily Newsletter would like to spotlight WhereverTV Broadcasting Corp. (TVTV).

WhereverTV Broadcasting Corp. (TVTV) is a next-generation OTT (Over-the-top) television subscription service that manages live-stream broadcast programming rights across multiple devices, geographies and languages, providing viewers with personalized service that is truly “wherever” they may be watching TV.

WhereverTV’s patented Interactive Program Guide (IPG) technology currently handles over 125 live channels that are broadcasted securely over the Internet to any Internet-enabled device anywhere in the world. Many of the company’s channels are the same as those broadcasted by traditional cable and satellite companies. For example, the World News Now package includes One America News, RT News (Russia Today), Bloomberg TV, CBN News and EuroNews Live — the latter provides pan-European coverage in 350 million households in 155 countries. Other channel packages include Choice TV (a wide variety of popular options for the family), Spanish TV, Faith TV and Morocco TV, providing current genre-specific subscriptions for news, faith, drama, sports, movie, reality and children’s programming.

WhereverTV’s free app works with iOS and Android devices to cover the spectrum of mobile consumer needs, as well as with personal desktop or laptop computers through its over the top (OTT) platform. The platform delivers channels, shows and events to SmartTVs and digital media receivers that include Google Chromecast, AppleTV, Amazon Fire TV, iPhone, iPad, Android Smartphone and TabletPCs, with DVR recording functionality slated for future development.

The company, based in Fort Myers, Florida, was developed in 2007 as a solution to its founder’s frustration with the complexities of trying to stream English speaking content while abroad.  As the live-streaming market has developed over the decade since then, WhereverTV has gained recognition as a pioneer in next-generation content delivery systems.

WhereverTV’s strategy is to increase revenue-generating subscriptions worldwide through the acquisition of content that is desirable to consumers and deliverable anywhere a device can connect to the Internet. Prepaid accounts will be accessed through the cloud, and the IPG technology will allow users to make their viewing choices. The company has developed two separate divisions, one for worldwide distribution and one for Latin American distribution.

In 2017, the company acquired Digital Rodeo, LLC, a Tennessee limited liability company that delivers a rich mixture of music and videos from independent country artists, current arrests and legacy artists, as well as similar Florida-based companies Digital RodeoTV, LLC (Name changed to WhereverTV Country in 2018), Digital CrossTV, Inc., Digital PopTV, Inc., and Digital RockTV, Inc.

WhereverTV is transitioning from a development to operational company and in doing so we have refined our 2018 business model,” CEO Edward D. Ciofani stated. “Our business model calls for content acquisition from around the world, exclusive content development, Major Marketing Alliances, similar to the announced Google Chromecast for Latin America and major marketing initiatives including social media marketing. … There are a lot of content providers (channel providers) around the world that offer a uniquely diversified perspective of cultures, travel and lifestyle content.”

As an increasing number of people “Cord-Cutters” no longer subscribe to the traditional cable or satellite distribution but rather a simpler lower cost means of watching content. The streaming OTT industry is expected to grow to $62 billion by 2020 — nearly triple its revenues in 2015, per Goldman Small Cap Research. Future Market Insights estimated the North America OTT market alone at $16.29 billion in 2017 with a CAGR of 17.4 percent through 2028. The arrival of 5G technology this year has the potential to accelerate the pace.

WhereverTV Broadcasting Corp. (TVTV), closed the day's trading session at $0.05, up 11.11%, on 10,459 volume with 2 trades. The average volume for the last 3 months is 27,392 and the stock's 52-week low/high is $0.0399/$0.46.

Recent News


Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software, Inc. (PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture, cannabis, and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Perceiving blockchain as an ideal mechanism for the complexities of the cannabis industry, Pacific Software will strive to improve the transparency, compliance, and efficiency of the “seed-to-sale” supply chain in states where the plant is legal.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $4.75, even for the day. The average volume for the last 3 months is 7 and the stock's 52-week low/high is $4.00/$5.25.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.